Our Discoveries & News
Tuesday, March 8, 2011
Commits $3.6 million for innovative studies to find new solutions for devastating disease with limited treatment options
Monday, December 6, 2010
LRI President Margaret G. Dowd comments: “Although the U.S. Food and Drug Administration (FDA) has postponed until March its decision on whether to approve Benlysta, the LRI remains encouraged by last month’s FDA Arthritis Advisory Committee’s vote to recommend the drug’s approval for the treatment of active lupus.”
Thursday, October 28, 2010
Lupus Research Institute Investigator’s Innovative Discovery of a Simple Blood Test for Lupus Flares Now Licensed for Development
On the go?
Text INFO to 50555 and opt-in to receive breaking news about lupus on your mobile phone.
Message and Data Rates May Apply. Text STOP to 50555 to STOP. Text HELP to 50555 for HELP. Full Terms